Dr. Lillian Siu is a Senior Medical Oncologist, Director of the Phase I Clinical Trials Program and holds the BMO Chair in Precision Genomics at the Princess Margaret Cancer Centre. She is globally recognized for her significant contributions in anticancer drug development, precision medicine and clinical trials methodology. She has led numerous clinical trials focusing on early phase therapeutic development of molecularly targeted agents, immunotherapeutics and novel cytotoxics. Her work has undoubtedly shaped the development of oncology agents globally within the context of genomic medicine and immunotherapy, enabling incorporation of this knowledge into clinical research practice to benefit patient outcomes.